Carrolee Barlow founded BrainCells, Inc. Presently, she is Chief Medical Officer for E-Scape Bio, Inc.
She is also on the board of Supernus Pharmaceuticals, Inc. and Orphazyme A.
In the past Dr. Barlow was Chief Medical Officer for Amicus Therapeutics, Inc., Chief Scientific & Medical Officer at BrainCells, Inc., Director-Molecular Neuroscience at Merck Research Laboratories Massachusetts LLC, Chief Executive Officer & Director at Parkinson's Institute & Clinical Center and Professor at The Salk Institute for Biological Studies.
Carrolee Barlow received a doctorate from Karolinska Institutet, an undergraduate degree from the University of Utah and a doctorate from the University of Utah School of Medicine.